miR-21 targets programmed cell death protein 4 (PDCD4), which suppresses proliferation, IL-10 production, CD40LG expression, and the capacity to drive B cell maturation in SLE CD4+ T cells [117,118,119,120]. Here, CD40LG is linked to systemic lupus erythematosus.